banner

An interactive day where key players and stakeholders will present the different driving forces in the Belgian clinical research ecosystem and the latest changes in the regulatory framework next to practical information and solutions. Financing aspects, patient involvement/recruitment and digitalisation will also be addressed in dedicated sessions along with testimonies of SMEs.

Belgium has a long history of excellent clinical research addressing a wide range of therapeutic domains thanks to a unique health ecosystem, the quality of the clinical centres and the real-life expertise of investigators.

Clinical research also refers to a multistakeholder landscape in which tracing its path can be a challenging task, in particular for SMEs willing to bring their health innovations ultimately to the patients. Areas of concern are effective implementation and conduct of clinical trials, as well as the timely recruitment of patients next to the structural funding of clinical research in hospitals.

As an output of a task force and to answer many of the questions life sciences SMEs are facing, BioWin and flanders.bio have jointly decided to organise for you this conference on clinical research in Belgium.

 

An interactive day where key players and stakeholders will present the different driving forces in the Belgian clinical research ecosystem and the latest changes in the regulatory framework next to practical information and solutions. Financing aspects, patient involvement/recruitment and digitalisation will also be addressed in dedicated sessions along with testimonies of SMEs.


Confirmed presence of FAMPH, Pharma.be, beMedTech, and BeCRO. Moderator for the day: Alain Wouters, Managing Director, Whole Systems

 

Sponsoring
Showcase your business to our attendees and engage with the audience at the start of the conference, during coffee and lunch breaks and during the closing reception.
Interested? Download our sponsorship guide and contact Marine Di Vincenzo to book your booth!

BioWin and flanders.bio retain the right to select the applying companies. 

 

Programme

09:00 - 09:30

Welcome

09:30 - 09:50

Introduction by flanders.bio and BioWin

Pascale Engelen, Co-Managing Director, flanders.bio and

Sylvie Ponchaut, Managing Director, BioWin

09:50 - 10:10

Belgium: an ambitious frontrunner in clinical trials

Catherine Rutten, CEO, pharma.be

 

10:10 - 10:30

MedTech trials in Belgium: Today and tomorrow

Marnix Denys, Managing Director, beMedTech

 

10:30 - 11:00

The clinical research area: challenges and opportunities from a FAMHP point of view .

Greet Musch, Director General PRE-authorisation, FAMHP

11:00 - 11:30

Coffee Break

11:30 - 11:50

Clinical research management: the point of vue of an academic hospital clinical trial center

Laurence Rimsky, Head Biomedical Research Center, Hôpital Erasme.

11:50 - 12:20

Selecting the right CRO partner when a SME enters in Clinical Trial phase: "Is bigger always better?”

Jean Van Rampelberg, Clinical4you/Director Clinical & Regulatory, Imcyse SA and

Cathy Scoupe, Training & Event responsible, BeCRO

12:20 - 13:00

Panel Dialog - Driving an effective patient enrolment and retention in clinical trials

Moderator: Thibault Helleputte, Founder & CEO, DNAlytics

 

13:00 - 14:00

Lunch

14:00 - 15:00

Session 1 - Clinical trials funding: from grants and tax incentives to private financing. What are the concrete levers?

Moderator: Stefaan Pijls, Principle Innovation Process Consultant, AYMING BENELUX

 

Speakers:

  • Guillaume de Viron, Partner, beLean.net/startupstudio.be
  • Jean-Luc Vandebroek, Executive Board Member & CFO, Bone Therapeutics

15:00 - 16:00

Session 2 - Driving an effective patient enrolment and retention in clinical trials

Moderator: Jami Norris ,VP Clinical Project Management, IQVIA

 

Speakers:

  • Barbara D’haene, Managing Director, Akcelis
  • Anne-Marie Hamoir, Senior Consultant, Patient Focus Medicine Development, TheSynergist.org
  • Christophe Lahorte, Head of Innovation Office & Scientific-Regulatory Advice Unit, FAMHP
  • Dominique Blankaert, Sr Director Clinical Project Management, Internal Medicine-Rare Disease, IQVIA
  • Heidi Muller, Director Patient Engagement Strategy, Janssen Pharmaceutica

16:00 - 16:30

Coffee Break

16:30 - 17:30

Session 3 - Digital transformation 4.0 in clinical trials. Where do we stand?

Moderator: Christophe Severs, Vice President Strategy Biopharma, Keyrus Group

 

Speakers:

  • Philip Allegaert, Director Big Data & Analytics, Keyrus
  • Gautier Sobczak, Co-Founder & Chief Business Officer, MyData-Trust
  • Valérie Kokoszka, Lecturer/Professor-Researcher, Centre d’Ethique Médicale, Université de Lille

17:30 - 17:45

Conclusions and take home messages

Alain Wouters, Managing Director, Whole Systems

17:45 - 18:30

Closing reception

Event Details

Date:

Thursday, January 16, 2020 (09:00 h - 18:30 h)

Location:

Square Brussels Convention Center

Mont des Arts, 1000 Bruxelles

www.square-brussels.com

Price:

BioWin & flanders.bio members: €100,-

Non-members: 180,-

 

*(VAT excl.)

Language:

English

Organiser(s):

BioWin and flanders.bio

2020-01-16 09:00:00 2020-01-16 18:30:00 Europe/Brussels Anchoring Clinical research in Belgium Square Brussels Convention Center Mont des Arts, 1000 Bruxelles www.square-brussels.com <p>BioWin and flanders.bio</p>

More info?

For any further information about this event, please do not hesitate to get in touch with our Event Coordinator

Alternate Text

Stefaan Galle

Event Coordinator

| |

Interested in a regular update of the Life Sciences and biotech sector in Flanders?